Overview of Gavi’s grant cycle

Eligible countries can implement a portfolio of Gavi support, consisting of;

  • health system strengthening (HSS) support
  • vaccine support
  • cold chain equipment optimisation platform (CCEOP) support
  • targeted country assistance (TCA)

Our support aims to assist countries in advancing their national immunisation plans and improving immunisation coverage and equity in a sustainable way.

Elearnings

Accessible to everyone.

Gavi iLearn

NEW GAVI SUPPORT

Over time, countries may request new Gavi support to be added to their existing portfolio. We strongly encourage them to base such requests on their national vision, and to align Gavi support with their own planning and financial cycles.

Requests for new support are reviewed by the Independent Review Committee (IRC). Once a request is approved, the funds or vaccines are sent to the country, marking the beginning of the implementation phase.

Gavi/2013/Evelyn Hockstein

IMPLEMENTATION

To renew their portfolio of Gavi support on a yearly basis, countries must regularly submit monitoring and reporting data. This includes an annual joint appraisal review of how Gavi-supported programmes are progressing, as well as regular reporting against set indicators through the grant performance framework. Regular reporting is key to monitoring the performance of Gavi support, and informs Gavi’s decisions on disbursements and renewals.

Applying or renewing support?

Transition

Gavi works closely with countries to ensure that investments support the long-term programmatic and financial sustainability of their immunisation programme. The ultimate goal is for countries to transition out of our support once they have robust systems and decision-making processes in place.

Gavi works closely with countries to ensure that investments support the long-term programmatic and financial sustainability of their immunisation programme. The ultimate goal is for countries to transition out of our support once they have robust systems and decision-making processes in place.

Deadlines

Countries should aim to meet a deadline that fits with their own timeframes for implementation. If a country misses a submission deadline, the request for new support or renewal will be reviewed in the following round.

All requests for renewal of vaccine support must be submitted by 15 May each year. In addition, countries should submit a joint appraisal report each year.

Countries should aim to meet a deadline that fits with their own timeframes for implementation. If a country misses a submission deadline, the request for new support or renewal will be reviewed in the following round.

All requests for renewal of vaccine support must be submitted by 15 May each year. In addition, countries should submit a joint appraisal report each year.

Deadlines to submit requests for new support

19 January 2021

4 May 2021

15 September 2021

Deadlines to submit joint appraisal reports

13 December 2019

31 March 2020

15 May 2020

8 September 2020

Welcome to Need to Know, a digital newsletter for countries and partners delivering the latest on Gavi policies, guidance, and other programmatic updates.

Access the previous editions using the links below.

Need to Know - 2021

25 AUGUST

Topics include:

  • Equity Accelerator Funding (EAF) Available for Countries to Accelerate Efforts to Reach Zero-dose Children and Missed Communities
  • EAF Application Pre-Requisites
  • Accessing Equity Accelerator Funding

3 AUGUST

Topics include:

  • Round 3 Opened for New Applications – Due Date 15 September
  • Key take-aways from the Vaccine High Level Review Panel (HLRP): 14-15 July 2021
  • Insights from meeting of the Independent Review Committee (IRC)

20 MAY

Topics include:

  • Gavi 5.0 Application Materials now available
  • Updated Vaccine Funding Guidelines released
  • Opening of Supplemental Application Round with submission deadline of 1 July 2021
  • New National Immunization Strategy (NIS) Guidelines to be available by end July 2021

14 APRIL

Topics include:

  • Application for Inactivated Polio Virus Second Dose Due on 4 May 2021
  • Accessing the country portal for renewals
  • Upcoming changes related to Gavi 5.0
  • Malaria Vaccine Implementation Programme (MVIP) – Update on 2nd anniversary
  • Key lessons learned from the first four years of implementation of the Cold Chain Equipment Optimization Platform (CCEOP)

4 MARCH

Topics include:

  • Upcoming Reporting Deadlines: Stock Reporting & GPF Reporting
  • Round 2 Opened for New Applications - Due Date 4 May
  • Requirement Waived for Countries with Expiring Comprehensive Multi-Year Plans
  • Immunisation Agenda 2030 Update
  • Need to Know Archive

27 JANUARY

Topics include:

  • Board Approval of Additional Financing to Accelerate Progress towards Equity in Immunisation
  • Gavi 5.0 Measurement Framework
  • Middle Income Country Approach Approved by the Board
  • Gavi Guidance to Address Gender-Related Barriers to Maintain, Restore, and Strengthen Immunisation in the Context of COVID-19
  • REMINDER: OneTA Plans for 2021 TCA Support to be Submitted by EPI Managers to Gavi Secretariat by 28 February 2021
  • TCV Introduction in Liberia and Zimbabwe 

Need to Know - 2020

15 DECEMBER

Topics include:

  • rotavirus vaccine profiles supported by Gavi
  • 2021 TCA guidance and support materials
  • resource kit for girl-focused communications for HPV campaigns 
  • cyber-security risks
  • insights from the latest IRC and HLRP meetings

3 DECEMBER – (COVAX NTK)

Topics include:

  • Update on Vaccine Request Form
  • Country Briefings on the COVAX Indemnification Agreement and COVAX Cost-Sharing
  • Communication of Cold Chain Equipment Support Ceilings.

25 NOVEMBER – (COVAX NTK)

Topics include:

  • COVAX Application Materials for AMC Eligible Economies Available in French, Spanish, and Russian
  • Follow-up to AMC Engagement Group Meeting - 19 November 2020

13 NOVEMBER – (COVAX NTK)

Topics include:

  • COVAX Application Materials for AMC Eligible Economies Now Available
  • AMC Engagement Group

12 NOVEMBER

Topics include:

  • Round Opened for New Applications - Due Date 19 January
  • Expanding partnerships to reach missed children in fragile and conflict settings
  • Recalibration of strategic priorities for Gavi 5.0 in light of Covid-19 and the successful replenishment
  • Using Geospatial Technologies to improve immunisation coverage and equity

8 OCTOBER

Topics include:

  • COVAX: Gavi Board approved funding to jumpstart support
  • Guidance for countries – maintaining, restoring and strengthening
  • Gavi's first ever innovation catalogue is available
  • Case Study: Understanding urban challenges in Uganda
  • Gavi's 2019 Annual Progress Report is out

9 SEPTEMBER

Topics include:

  • Gavi’s support in the face of COVID-19: updated programming guidance coming soon
  • Learn and adapt to increase access to immunisation
  • Cambodia: performance of an immunisation system under COVID-19
  • Key take-aways from the Vaccine High Level Review Panel (HLRP) 
  • Coming soon: Gavi's 2019 Annual Progress Report
  • July IRC report released
  • Multi-stakeholder dialogue planning

30 JULY

Topics include:

  • Support approved for former-Gavi countries
  • PEF Targeted Country Assistance (TCA) June 2020 Reporting: COVID-19 impacts achievement rate
  • Gavi Independent Review Committee Insights
  • What We Learned: Supportive supervision of frontline workers case study
  • COVID-19 Vaccines Global Access (COVAX) Facility
  • Need to Know Archive

14 JULY

Topics include:

  • New COVID-19 Vaccines Global Access (COVAX)
  • COVID-19 & Immunisation multi-stakeholder dialogue
  • 2020 Applications – Round three due 8 September
  • Gavi’s new Gender Policy
  • How Health Systems Immunisation Strengthening (HSIS) is changing
  • Programme readiness filter removed.

18 JUNE

Topics include:

  • Exceptional measures to support countries mitigate the fiscal impact of the COVID-19 pandemic on immunisation
  • Requirement Waived for Countries with Expiring Comprehensive Multi-Year Plans
  • Targeted Country Assistance Flexibility
  • PEF Partners Progress Reporting on Strategic Focus Areas (SFA), Targeted Country Assistance (TCA), and Post Transition Engagement in Partner Portal
  • Inactivated Poliovirus Vaccine Second Dose Requests Due 15 July
  • 2021 Yellow Fever Diagnostic Support Renewals.
Last updated: 25 Aug 2021

Subscribe to our newsletter